Clinical trial Recruiting at 1 site Interventional Ages 18 to 100

Improving muscle strength and reducing pain in amputees using electrical stimulation

Official title: Detecting Change in Muscle Parameters, Pain, and Function With Neuromuscular Electrical Stimulation Treatment in Individuals Living With Transtibial Amputation

Run by O&P Clinical Innovations · NCT06830876 · Data updated 2026-11-12

This study is testing a home-based electrical stimulation program to see if it can help people with a leg amputation build muscle strength and reduce pain.

Quick facts

Study typeInterventional
Ages18 Years to 100 Years
SexAll
Enrollment20 (estimated)
SponsorO&P Clinical Innovations
Industry-sponsored
Locations1 site (Pittsburgh, Pennsylvania)
StatusRecruiting
StartedDecember 10, 2024
Main results expectedAugust 30, 2025
Study endsDecember 30, 2025
Registry record updatedFebruary 17, 2025
Trial IDNCT06830876 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with a unilateral transtibial amputation who experience moderate pain and have adequate sensation in their residual limb.

Probably not a fit

Patients with severe diabetes, open wounds on the residual limb, or those who have recently used electrical stimulation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of a home-based Neuromuscular Electrical Stimulation (NMES) program for individuals with unilateral transtibial amputation. Over eight weeks, participants will use a portable NMES device to stimulate muscle growth and improve function in their residual limb. The study will assess changes in muscle parameters, pain levels, and gait biomechanics through ultrasound imaging and self-reported measures. The goal is to enhance mobility and overall well-being for amputees by addressing muscle atrophy and pain.

Why it matters

Potential benefit: If successful, this intervention could significantly improve muscle strength, reduce pain, and enhance mobility for amputees.

How similar studies have gone: Previous studies have shown promising results with NMES in improving muscle function in various populations, suggesting potential success for this approach in amputees.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years or older
* Have a unilateral transtibial amputation
* Have normal sound limb range of motion and function
* Have a minimum of 4" length limb from tibial tubercle to end of residuum to allow room for NMES pads
* Report current pain at a level 3 or higher on a Visual Analog Scale (VAS)
* Pass a monofilament test on the residual limb in 7 out of 10 areas to ensure adequate sensation for NMES stimulation
* Have a body mass index (BMI) of 35 kg/cm2 or less as NMES works more effectively on lower BMI

Exclusion Criteria:

* Have used electrical stimulation on the residual limb in the past six months
* Have been diagnosed as a severe diabetic or self-report insensate skin
* Have the presence of open wounds/ulcers on the residual limb
* Have experienced a cerebrovascular accident (stroke) or nerve injury to a lower limb
* Wear a pacemaker or implanted cardiac defibrillator

Where it's running

  • Cranberry Township Building
    Pittsburgh, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.